Central tolerance regulates B cells reactive with goodpasture antigen α3(IV)NC1 collagen

Journal of Immunology

Volumn 181, Issue 9, 2008, Pages 6092-6100

  Zhang, Ying ^a   Su, Susan C ^a   Hecox, Douglas B ^a   Brady, Graham F ^a   Mackin, Katherine M ^a   Clark, Amy G ^a   Foster, Mary H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; EPITOPE; GOODPASTURE ANTIGEN ALPHA3(IV)NC1 COLLAGEN; IMMUNOGLOBULIN G; RAG1 PROTEIN; RAG2 PROTEIN; UNCLASSIFIED DRUG; AUTOANTIBODY; AUTOANTIGEN; COLLAGEN TYPE 4; HOMEODOMAIN PROTEIN; MONOCLONAL ANTIBODY; RAG 1 PROTEIN; RAG-1 PROTEIN; TYPE IV COLLAGEN ALPHA3 CHAIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BONE MARROW; CONTROLLED STUDY; FEMALE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE SUBPOPULATION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RNA EDITING; TRANSGENIC MOUSE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; DISEASE MODEL; GENETICS; GLOMERULONEPHRITIS; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; AUTOANTIGENS; B-LYMPHOCYTE SUBSETS; CELL LINE, TUMOR; COLLAGEN TYPE IV; DISEASE MODELS, ANIMAL; HOMEODOMAIN PROTEINS; HUMANS; IMMUNE TOLERANCE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC;

EID: 58749109186     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.9.6092     Document Type: Article

References (71)

1. Wieslander, J., J. F. Barr, R. J. Butkowski, S. J. Edwards, P. Bygren, D. Heinegard, and B. G. Hudson. 1984. Goodpasture antigen of the glomerular basement membrane: localization to noncollagenous regions of type IV collagen. Proc. Natl. Acad. Sci. USA 81: 3838-3842. (Pubitemid 14087813)
2. Saus, J., J. Wieslander, J. Langeveld, S. Quinones, and B. Hudson. 1988. Identification of the Goodpasture antigen as the α3(IV) chain of collagen IV. J. Biol. Chem. 263: 13374-13380. (Pubitemid 18238416)
3. Wang, X. P., A. B. Fogo, S. Colon, G. Giannico, S. R. Abul-Ezz, J. H. Miner, and D. B. Borza. 2005. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and Goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen. J. Am. Soc. Nephrol. 16: 3563-3571.
4. Hamano, Y., M. Zeisberg, H. Sugimoto, J. C. Lively, Y. Maeshima, C. Yang, R. O. Hynes, Z. Werb, A. Sudhakar, and R. Kalluri. 2003. Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV α3 integrin. Cancer Cell 3: 589-601. (Pubitemid 36808653)
5. Netzer, K. O., A. Leinonen, A. Boutaud, D. B. Borza, P. Todd, S. Gunwar, J. P. Langeveld, and B. G. Hudson. 1999. The Goodpasture autoantigen: mapping the major conformational epitope(s) of alpha3(IV) collagen to residues 17-31 and 127-141 of the NC1 domain. J. Biol. Chem. 274: 11267-11274. (Pubitemid 129528340)
6. Borza, D. B., K. O. Netzer, A. Leinonen, P. Todd, J. Cervera, J. Saus, and B. G. Hudson. 2000. The Goodpasture autoantigen. Identification of multiple cryptic epitopes on the NC1 domain of the alpha3(IV) collagen chain. J. Biol. Chem. 275: 6030-6037.
7. Borza, D., O. Bondar, P. Todd, M. Sundaramoorthy, Y. Sado, Y. Ninomiya, and B. Hudson. 2002. Quaternary organization of the Goodpasture autoantigen, the α 3(IV) collagen chain: sequestration of two cryptic autoepitopes by intrapromoter interactions with the alpha4 and alpha5 NC1 domains. J. Biol. Chem. 277: 40075-40083. (Pubitemid 35190997)
8. Borza, D. B., and B. G. Hudson. 2003. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease. Springer Semin. Immunopathol. 24: 345-361. (Pubitemid 36683393)
9. Borza, D. B., O. Bondar, S. Colon, P. Todd, Y. Sado, E. G. Neilson, and B. G. Hudson. 2005. Goodpasture autoantibodies unmask cryptic epitopes by selectively dissociating autoantigen complexes lacking structural reinforcement: novel mechanisms for immune privilege and autoimmune pathogenesis. J. Biol. Chem. 280: 27147-27154.
10. Wilson, C. B. 1997. Immune Models of Glomerular Injury. In Immunologic Renal Diseases. E. G. Neilson and W. G. Couser, eds. Lippincott-Raven, Philadelphia, pp. 729-774.
11. Kalluri, R., L. Cantley, D. Kerjaschki, and E. Neilson. 2000. Reactive oxygen species expose cryptic epitopes associated with autoimmune Goodpasture syndrome. J. Biol. Chem. 275: 20027-20032. (Pubitemid 30441611)
12. Cui, Z., H. Wang, and M. Zhao. 2006. Natural autoantibodies against glomerular basement membrane exist in normal human sera. Kidney Int. 69: 894-899. (Pubitemid 43297901)
13. Derry, C. J., C. N. Ross, G. Lombardi, P. D. Mason, A. J. Rees, R. I. Lechler, and C. D. Pusey. 1995. Analysis of T-cell responses to the autoantigen in Goodpasture's disease. Clin. Exp. Immunol. 100: 262-268.
14. Merkel, F., R. Kalluri, M. Marx, U. Enders, S. Stevanovic, G. Giegerich, E. G. Neilson, H. Rammensee, B. G. Hudson, and M. Weber. 1996. Autoreactive T-cells in Goodpasture's syndrome recognize the N-terminal NCI domain on a3 type 1V collagen. Kidney Int. 49: 1127-1133. (Pubitemid 26122716)
15. + T cells escape thymic deletion and are reactive with the autoantigen alpha3(IV)NC1. J. Am. Soc. Nephrol. 12: 1908-1915.
16. Wong, D., R. G. Phelps, and A. N. Turner. 2001. The Goodpasture antigen is expressed in the human thymus. Kidney Int. 60: 1777-1783. (Pubitemid 32999982)
17. Kalluri, R., T. M. Danoff, H. Okada, and E. G. Neilson. 1997. Susceptibility to anti-glomerular basement membrane disease and Goodpasture syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice. J. Clin. Invest. 100: 2263-2275. (Pubitemid 27500149)
18. Sackey, F. N., K. L. Congdon, G. F. Brady, H. Hopfer, Y. Zhang, K. M. Mackin, and M. H. Foster. 2008. Shared variable domain elements among anti-collagen antibodies reactive with Goodpasture epitopes. In Autoimmunity: Role, Regulation, and Disorder. F. L. Vogel and L. F. Zimmermann, eds. Nova Science Publishers, Hauppauge, NY. In press.
19. Fitzsimons, M. M., H. Chen, and M. H. Foster. 2000. Diverse endogenous light chains contribute to basement membrane reactivity in nonautoimmune mice transgenic for an anti-laminin Ig heavy chain. Immunogenetics 51: 20-29.
20. Foster, M., Q. Liu, H. Chen, D. Nemazee, and B. Cooperstone. 1997. Antilaminin reactivity and glomerular immune deposition by in vitro recombinant antibodies. Autiommunity 26: 231-243. (Pubitemid 28105206)
21. Cooperstone, B. G., M. M. Rahman, E. H. Rudolph, and M. H. Foster. 2001. In vitro and in vivo expression of a nephritogenic Ig heavy chain determinant: pathogenic autoreactivity requires permissive light chains. Immunol. Cell Biol. 79: 222-230.
22. Pelanda, R., S. Schaal, R. M. Torres, and K. Rajewsky. 1996. A prematurely expressed Igκ transgene, but not VκJκ gene segment targeted into the Igκ locus, can rescue B cell development in λ5-deficient mice. Immunity 5: 229-239. (Pubitemid 26341366)
23. Rudolph, E. H., K. L. Congdon, F. N. Sackey, M. M. Fitzsimons, and M. H. Foster. 2002. Humoral autoimmunity to basement membrane antigens is regulated in C57BL/6 and MRL/MpJ mice transgenic for anti-laminin Ig receptors. J. Immunol. 168: 5943-5953.
24. Brady, G. F., K. L. Congdon, A. G. Clark, F. N. Sackey, E. H. Rudolph, M. Z. Radic, and M. H. Foster. 2004. κ editing rescues autoreactive B cells destined for deletion in mice transgenic for a dual specific anti-laminin Ig. J. Immunol. 172: 5313-5321.
25. Wieslander, J., J. Langeveld, R. Butkowski, M. Jodlowski, M. Noelken, and B. G. Hudson. 1985. Physical and immunochemical studies of the globular domain of type IV collagen: cryptic properties of the Goodpasture antigen. J. Biol. Chem. 260: 8564-8570. (Pubitemid 15011831)
26. Goodnow, C. C., J. Crosbie, S. Adelstein, T. B. Lavoie, S. J. Smith-Gill, R. A. Brink, H. Pritchard-Briscoe, J. S. Wotherspoon, R. H. Loblay, K. Raphael, et al. 1988. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334: 676-682.
27. Shinkai, Y., G. Rathbun, K. P. Lam, E. M. Oltz, V. Stewart, M. Mendelsohn, J. Charron, M. Datta, F. Young, A. M. Stall, and F. W. Alt. 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68: 855-867.
28. Radic, M. Z., J. Erikson, S. Litwin, and M. Weigert. 1993. B lymphocytes may escape tolerance by revising their antigen receptors. J. Exp. Med. 177: 1165-1173.
29. Gay, D., T. Saunders, S. Camper, and M. Weigert. 1993. Receptor editing: An approach by autoreactive B cells to escape tolerance. J. Exp. Med. 177: 999-1008. (Pubitemid 23097389)
30. Tiegs, S. L., D. M. Russell, and D. Nemazee. 1993. Receptor editing in selfreactive bone marrow B cells. J. Exp. Med. 177: 1009-1020. (Pubitemid 23097390)
31. Han, S., S. R. Dillon, B. Zheng, M. Shimoda, M. S. Schlissel, and G. Kelsoe. 1997. V(D)J recombinase activity in a subset of germinal center B lymphocytes. Science 278: 301-305. (Pubitemid 27450879)
32. Kenny, J. J., L. J. Rezanka, A. Lustig, R. T. Fischer, J. Yoder, S. Marshall, and D. L. Longo. 2000. Autoreactive B cells escape clonal deletion by expressing multiple antigen receptors. J. Immunol. 164: 4111-4119.
33. Cyster, J., S. Hartley, and C. Goodnow. 1994. Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature 371: 389-395. (Pubitemid 24302553)
34. Schmidt, K. N., and J. G. Cyster. 1999. Follicular exclusion and rapid elimination of hen egg lysozyme autoantigen-binding B cells are dependent on competitor B cells, but not on T cells. J. Immunol. 162: 284-291.
35. Ekland, E. H., R. Forster, M. Lipp, and J. G. Cyster. 2004. Requirements for follicular exclusion and competitive elimination of autoantigen-binding B cells. J. Immunol. 172: 4700-4708.
36. Seo, S., M. L. Fields, J. L. Buckler, A. J. Reed, L. Mandik-Nayak, S. A. Nish, L. A. Turka, F. D. Finkelman, A. J. Caton, and J. Erikson. 2002. The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells. Immunity 16: 535-546. (Pubitemid 34442578)
37. + regulatory T cells. J. Immunol. 175: 4180-4183.
38. Spanopoulou, E., C. A. J. Roman, L. M. Corcoran, M. S. Schlissel, D. P. Silver, D. Nemazee, M. C. Nussenzweig, S. Shinton, R. R. Hardy, and D. Baltimore. 1994. Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice. Genes Dev. 8: 1030. (Pubitemid 24985785)
39. Xu, H., H. Li, E. Suri-Payer, R. Hardy, and M. Weigert. 1998. Regulation of anti-DNA B cells in recombination-activating gene-deficient mice. J. Exp. Med. 188: 1247-1254. (Pubitemid 28478013)
40. Halverson, R., R. M. Torres, and R. Pelanda. 2004. Receptor editing is the main mechanism of B cell tolerance toward membrane antigens. Nat. Immunol. 5: 645-650. (Pubitemid 38811890)
41. Maeshima, Y., P. C. Colorado, A. Torre, K. A. Holthaus, J. A. Grunkemeyer, M. B. Ericksen, H. Hopfer, Y. Xiao, I. E. Stillman, and R. Kalluri. 2000. Distinct antitumor properties of a type IV collagen domain derived from basement membrane. J. Biol. Chem. 275: 21340-21348. (Pubitemid 30481833)
42. Hamano, Y., and R. Kalluri. 2005. Tumstatin, the NC1 domain of alpha3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth. Biochem. Biophys. Res. Commun. 333: 292-298. (Pubitemid 40848291)
43. Hippen, K. L., B. R. Schram, L. E. Tze, K. A. Pape, M. K. Jenkins, and T. W. Behrens. 2005. In vivo assessment of the relative contributions of deletion, anergy, and editing to B cell self-tolerance. J. Immunol. 175: 909-916.
44. Pelanda, R., and R. M. Torres. 2006. Receptor editing for better or for worse. Curr. Opin. Immunol. 18: 184-190.
45. Casellas, R., T. A. Shih, M. Kleinewietfeld, J. Rakonjac, D. Nemazee, K. Rajewsky, and M. C. Nussenzweig. 2001. Contribution of receptor editing to the antibody repertoire. Science 291: 1541-1544. (Pubitemid 32179219)
46. Yuan, D., and T. Dang. 1997. Effect of the presence of transgenic H and L chain genes on B cell development and allelic exclusion. Int. Immunol. 9: 1651-1661. (Pubitemid 27494128)
47. Ait-Azzouzene, D., L. Verkoczy, J. Peters, A. Gavin, P. Skog, J. L. Vela, and D. Nemazee. 2005. An immunoglobulin C κ-reactive single chain antibody fusion protein induces tolerance through receptor editing in a normal polyclonal immune system. J. Exp. Med. 201: 817-828. (Pubitemid 40395125)
48. Radic, M. Z., M. A. Mascelli, J. Erikson, H. Shan, and M. Weigert. 1991. Ig H and L chain contributions to autoimmune specificities. J. Immunol. 146: 176-182.
49. Chu, Y. P., L. Spatz, and B. Diamond. 2004. A second heavy chain permits survival of high affinity autoreactive B cells. Autoimmunity 37: 27-32.
50. ten Boekel, E., F. Melchers, and A. G. Rolink. 1998. Precursor B cells showing H chain allelic inclusion display allelic exclusion at the level of pre-B cell receptor surface expression. Immunity 8: 199-207.
51. Kitamura, D., and K. Rajewsky. 1992. Targeted disruption of μ chain membrane exon causes loss of heavy-chain allelic exclusion. Nature 356: 154-156.
52. Stall, A. M., F. G. M. Kroese, F. T. Gadus, D. G. Sieckmann, L. A. Herzenberg, and L. A. Herzenberg. 1988. Rearrangement and expression of endogenous immunoglobulin genes occur in many murine B cells expressing transgenic membrane IgM. Proc. Natl. Acad. Sci. USA 85: 3546-3550.
53. Goodnow, C. C. 1992. Transgenic mice and analysis of B-cell tolerance. Annu. Rev. Immunol. 10: 489-518.
54. Imanishi-Kari, T., S. Bandyopadhay, P. Busto, and C. A. Huang. 1993. Endogenous Ig production in mu transgenic mice: I. Allelic exclusion at the level of expression. J. Immunol. 150: 3311-3326. (Pubitemid 23129710)
55. Taki, S., M. Meiering, and K. Rajewsky. 1993. Targeted insertion of a variable region gene into the immunoglobulin heavy chain locus. Science 262: 1268-1271. (Pubitemid 24036093)
56. Nussenzweig, M. C., A. C. Shaw, E. Sinn, D. B. Danner, K. L. Holmes, H. C. Morse III, and P. Leder. 1987. Allelic exclusion in transgenic mice that express the membrane form of immunoglobulin μ. Science 236: 816-819. (Pubitemid 17071155)
57. Manz, J., K. Denis, O. Witte, R. Brinster, and U. Storb. 1988. Feedback inhibition of immunoglobulin gene rearrangement by membrane μ, but not by secreted μ heavy chains. J. Exp. Med. 168: 1363-1381. (Pubitemid 18264871)
58. Sonoda, E., Y. Pewzner-Jung, S. Schwers, S. Taki, S. Jung, D. Eilat, and K. Rajewsky. 1997. B cell development under the condition of allelic inclusion. Immunity 6: 225-233. (Pubitemid 27148589)
59. Fulcher, D. A., A. B. Lyons, S. L. Korn, M. C. Cook, C. Koleda, C. Parish, B. Fazekas de St. Groth, and A. Basten. 1996. The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J. Exp. Med. 183: 2313-2328.
60. Lesley, R., L. M. Kelly, Y. Xu, and J. G. Cyster. 2006. Naive CD4 T cells constitutively express CD40L and augment autoreactive B cell survival. Proc. Natl. Acad. Sci. USA 103: 10717-10722. (Pubitemid 44078043)
61. Noorchashm, H., A. Bui, H. Li, A. Eaton, L. Mandik-Nayak, C. Sokol, K. Potts, E. Pure, and J. Erikson. 1999. Characterization of anergic anti-DNA B cells: B cell anergy is a T cell-independent and potentially reversible process. Int. Immunol. 11: 765-776. (Pubitemid 29237768)
62. Nagasawa, T. 2006. Microenvironmental niches in the bone marrow required for B-cell development. Nat. Rev. Immunol. 6: 107-116. (Pubitemid 43361586)
63. Kaushik, A., G. Kelsoe, and J. C. Jaton. 1995. The nude mutation results in impaired primary antibody repertoire. Eur. J. Immunol. 25: 631-634.
64. Gollahon, K. A., J. Hagman, R. L. Brinster, and U. Storb. 1988. Ig λ-producing B cells do not show feedback inhibition of gene rearrangement. J. Immunol. 141: 2771-2780.
65. Gerdes, T., and M. Wabl. 2004. Autoreactivity and allelic inclusion in a B cell nuclear transfer mouse. Nat. Immunol. 5: 1282-1287. (Pubitemid 41057744)
66. Casellas, R., Q. Zhang, N. Y. Zheng, M. D. Mathias, K. Smith, and P. C. Wilson. 2007. Igκ allelic inclusion is a consequence of receptor editing. J. Exp. Med. 204: 153-160. (Pubitemid 46148765)
67. Li, Y., H. Li, and M. Weigert. 2002. Autoreactive B cells in the marginal zone that express dual receptors. J. Exp. Med. 195: 181-188. (Pubitemid 34461262)
68. Liu, S., M. G. Velez, J. Humann, S. Rowland, F. J. Conrad, R. Halverson, R. M. Torres, and R. Pelanda. 2005. Receptor editing can lead to allelic inclusion and development of B cells that retain antibodies reacting with high avidity autoantigens. J. Immunol. 175: 5067-5076. (Pubitemid 41456390)
69. Manz, R. A., A. E. Hauser, F. Hiepe, and A. Radbruch. 2005. Maintenance of serum antibody levels. Annu. Rev. Immunol. 23: 367-386.
70. Shlomchik, M. J., J. E. Craft, and M. J. Mamula. 2001. From T to B and back again: positive feedback in systemic autoimmune disease. Nat. Rev. 1: 147-153.
71. Sekiguchi, D., R. Eisenberg, and M. Weigert. 2003. Secondary heavy chain rearrangement: a mechanism for generating anti-double-stranded DNA B cells. J. Exp. Med. 197: 27-39. (Pubitemid 36110255)